EWTX - Edgewise Therapeutics Inc
IEX Last Trade
18.74
0.320 1.708%
Share volume: 1,131,045
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$18.42
0.32
1.74%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-3.00%
1 Month
10.04%
3 Months
7.14%
6 Months
12.61%
1 Year
203.40%
2 Year
87.88%
Key data
Stock price
$18.74
DAY RANGE
N/A - N/A
52 WEEK RANGE
$5.12 - $23.50
52 WEEK CHANGE
$1.91
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO:
Region: US
Website: edgewisetx.com
Employees: 79
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: edgewisetx.com
Employees: 79
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.
Recent news